IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 335 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,065 | +2.2% | 45,522 | -7.6% | 0.10% | +10.2% |
Q2 2023 | $2,021 | -3.6% | 49,252 | -16.0% | 0.09% | -11.1% |
Q1 2023 | $2,096 | -24.6% | 58,652 | -20.3% | 0.10% | -35.7% |
Q4 2022 | $2,778 | -99.9% | 73,547 | +20.7% | 0.15% | -5.5% |
Q3 2022 | $2,695,000 | +192.3% | 60,937 | +144.7% | 0.16% | +136.2% |
Q2 2022 | $922,000 | +86.6% | 24,900 | +86.6% | 0.07% | +115.6% |
Q1 2022 | $494,000 | -57.7% | 13,344 | -65.3% | 0.03% | -78.1% |
Q4 2021 | $1,169,000 | +48.5% | 38,430 | +63.7% | 0.15% | +39.0% |
Q3 2021 | $787,000 | – | 23,474 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |